Sally Medhat Kamal, MD | |
2025 Morse Ave, Sacramento, CA 95825-2115 | |
(916) 298-9182 | |
Not Available |
Full Name | Sally Medhat Kamal |
---|---|
Gender | Female |
Speciality | |
Experience | Years |
Location | 2025 Morse Ave, Sacramento, California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1093973026 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Y00000X | Otolaryngology | A109965 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Sally Medhat Kamal, MD 2025 Morse Ave, Sacramento, CA 95825-2115 Ph: (916) 298-9182 | Sally Medhat Kamal, MD 2025 Morse Ave, Sacramento, CA 95825-2115 Ph: (916) 298-9182 |
News Archive
Takeda Pharmaceutical Company Limited today announced that the U.S. Food and Drug Administration has approved NINLARO (ixazomib) capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy. NINLARO is a once-weekly pill.
"[T]he White House team is retooling its message and strategy, hoping a more modest approach will reinvigorate Obama's signature domestic policy initiative and give him a first-year victory for Democrats to carry into the 2010 midterm elections," the Washington Post reports.
A novel robotic system that can operate inside the bore of an MRI scanner is currently being tested as part of a biomedical research partnership program at Brigham and Women's Hospital in Boston with the aim of determining if the robot, in conjunction with real-time MRI images, can make prostate cancer biopsies faster, more accurate, less costly, and less discomforting for the patient.
EnGeneIC Ltd., an emerging biopharmaceutical company focused on developing its proprietary EDV™ nanocell platform for the targeted delivery of cancer therapeutics, today announced that the first patient has been dosed in its Phase 1 Tailored-EDV trial. The trial is being conducted at the Northern Cancer Institute in Sydney, Australia.
NextGen Healthcare Information Systems, LLC., a wholly owned subsidiary of Quality Systems, Inc. (NASDAQ: QSII) and a leading provider of healthcare information systems and connectivity solutions, announced today that T-System, Inc., will deploy NextGen® Practice Management to help drive revenue cycle management billing for its clients, which span across the U.S.
› Verified 4 days ago
Richard S. Isaacs, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 6600 Bruceville Rd, Sacramento, CA 95823 Phone: 916-688-2000 | |
Montague G. Carr, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2025 Morse Ave, Sacramento, CA 95825 Phone: 916-973-5000 | |
Dr. Rodney C. Diaz, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2521 Stockton Blvd, Suite 7200, Sacramento, CA 95817 Phone: 916-734-3744 Fax: 916-703-5011 | |
Deborah Helen Amott, M.D Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 2521 Stockton Blvd, Suite 7200, Sacramento, CA 95817 Phone: 916-734-2801 Fax: 916-703-5011 | |
Nina Wanning Zhao, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2521 Stockton Blvd Ste 7200, Sacramento, CA 95817 Phone: 415-476-4952 | |
Anton Chen, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2025 Morse Ave, Sacramento, CA 95825 Phone: 916-973-5000 |